Jonathan Govette, CEO of Oatmeal Health

Lung cancer is the #1 cancer killer in the U.S., yet only about 18% of eligible high-risk patients are ever screened, and most cases are still caught late. Oatmeal Health is closing that gap.

Our AI CADx reads a lung CT and scores each nodule's malignancy risk, giving radiologists a consistent, objective answer to the question that matters most: is it cancer? We model how a nodule changes between the prior and current scan, the way radiologists actually diagnose, so high-risk patients move faster to treatment and low-risk patients avoid unnecessary biopsies.

Earlier detection. Fewer unnecessary procedures. Lower total cost of care.

Learn more at oatmealhealth.com
Jonathan Govette, Co-Founder and CEO
Pre-FDA 510(k) Clearance